Patent · US Active

Chemoembolization composition comprising anti-angiogenic agents

US10537643B2 · kind B2 · utility

0Cited by

0References

33Claims

0Family size

Assignee

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (C.H.U.V.) · CH

Inventors

Alban Denys · Lausanne, CH
Pierre Bize · Cheseaux, CH
Olivier Jordan · Prangins, CH
Eric Doelker · Veyrier, CH
Nathalie Boulens · Confignon, CH

Key dates

Filing date	Jun 29, 2017
Grant date	Jan 21, 2020
Priority date	—
Expiry date	Nov 23, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to chemoembolization compositions for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization compositions and to the use of chemoembolization compositions in the method for treating solid tumour cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.